Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) EBT Margin: 2019-2025

Historic EBT Margin for Eton Pharmaceuticals (ETON) over the last 6 years, with Sep 2025 value amounting to -8.70%.

  • Eton Pharmaceuticals' EBT Margin fell 1356.00% to -8.70% in Q3 2025 from the same period last year, while for Sep 2025 it was -11.83%, marking a year-over-year decrease of 254.00%. This contributed to the annual value of -9.76% for FY2024, which is 758.00% down from last year.
  • According to the latest figures from Q3 2025, Eton Pharmaceuticals' EBT Margin is -8.70%, which was up 34.59% from -13.31% recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' EBT Margin ranged from a high of 43.00% in Q1 2021 and a low of -786.32% during Q3 2021.
  • Moreover, its 3-year median value for EBT Margin was -8.70% (2025), whereas its average is -15.97%.
  • Examining YoY changes over the last 5 years, Eton Pharmaceuticals' EBT Margin showed a top increase of 2,358,427bps in 2021 and a maximum decrease of 25,621,628bps in 2021.
  • Quarterly analysis of 5 years shows Eton Pharmaceuticals' EBT Margin stood at 17.05% in 2021, then tumbled by 632bps to 10.73% in 2022, then plummeted by 1,747bps to -6.74% in 2023, then spiked by 235bps to -4.39% in 2024, then crashed by 1,356bps to -8.70% in 2025.
  • Its EBT Margin was -8.70% in Q3 2025, compared to -13.31% in Q2 2025 and -83.87% in Q1 2025.